SynCore Biotechnology Co.,Ltd (TPEX:4192)

TPEX:4192 Revenue

SynCore Biotechnology Co.,Ltd had revenue of 6.47M TWD in the quarter ending September 30, 2025, with 22.29% growth. This brings the company's revenue in the last twelve months to 26.26M, up 14.51% year-over-year. In the year 2024, SynCore Biotechnology Co.,Ltd had annual revenue of 23.34M with 15.55% growth.

• Revenue (ttm): 26.26M
• Revenue Growth: +14.51%
• P/S Ratio: 32.68
• Revenue / Employee: 656.43K
• Employees: 40
• Market Cap: 858.03M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	23.34M	3.14M	15.55%
Dec 31, 2023	20.20M	4.34M	27.36%
Dec 31, 2022	15.86M	8.92M	128.52%
Dec 31, 2021	6.94M	-6.40M	-47.97%
Dec 31, 2020	13.34M	369.00K	2.85%